Shen D - Search Results

1

Aberrant promoter methylation of hOGG1 may be associated with increased risk of non-small cell lung cancer.

Qin H, Zhu J, Zeng Y, Du W, Shen D, Lei Z, Qian Q, Huang JA, Liu Z. Qin H, et al. Among authors: shen d. Oncotarget. 2017 Jan 31;8(5):8330-8341. doi: 10.18632/oncotarget.14177. Oncotarget. 2017. PMID: 28039450 Free PMC article.

2

Expression profile analysis of microRNAs and downregulated miR-486-5p and miR-30a-5p in non-small cell lung cancer.

Zhu J, Zeng Y, Xu C, Qin H, Lei Z, Shen D, Liu Z, Huang JA. Zhu J, et al. Among authors: shen d. Oncol Rep. 2015 Oct;34(4):1779-86. doi: 10.3892/or.2015.4141. Epub 2015 Jul 21. Oncol Rep. 2015. PMID: 26238736

3

Repression of Smad4 by miR‑205 moderates TGF-β-induced epithelial-mesenchymal transition in A549 cell lines.

Zeng Y, Zhu J, Shen D, Qin H, Lei Z, Li W, Huang JA, Liu Z. Zeng Y, et al. Among authors: shen d. Int J Oncol. 2016 Aug;49(2):700-8. doi: 10.3892/ijo.2016.3547. Epub 2016 May 31. Int J Oncol. 2016. PMID: 27279345

4

The EGFR pathway is involved in the regulation of PD-L1 expression via the IL-6/JAK/STAT3 signaling pathway in EGFR-mutated non-small cell lung cancer.

Zhang N, Zeng Y, Du W, Zhu J, Shen D, Liu Z, Huang JA. Zhang N, et al. Among authors: shen d. Int J Oncol. 2016 Oct;49(4):1360-8. doi: 10.3892/ijo.2016.3632. Epub 2016 Jul 26. Int J Oncol. 2016. PMID: 27499357

5

Bevacizumab combined with chemotherapy for ovarian cancer: an updated systematic review and meta-analysis of randomized controlled trials.

Wu YS, Shui L, Shen D, Chen X. Wu YS, et al. Among authors: shen d. Oncotarget. 2017 Feb 7;8(6):10703-10713. doi: 10.18632/oncotarget.12926. Oncotarget. 2017. PMID: 27793044 Free PMC article. Review.

6

CD73/NT5E is a target of miR-30a-5p and plays an important role in the pathogenesis of non-small cell lung cancer.

Zhu J, Zeng Y, Li W, Qin H, Lei Z, Shen D, Gu D, Huang JA, Liu Z. Zhu J, et al. Among authors: shen d. Mol Cancer. 2017 Feb 3;16(1):34. doi: 10.1186/s12943-017-0591-1. Mol Cancer. 2017. PMID: 28158983 Free PMC article.

7

MicroRNA-205 targets SMAD4 in non-small cell lung cancer and promotes lung cancer cell growth in vitro and in vivo.

Zeng Y, Zhu J, Shen D, Qin H, Lei Z, Li W, Liu Z, Huang JA. Zeng Y, et al. Among authors: shen d. Oncotarget. 2017 May 9;8(19):30817-30829. doi: 10.18632/oncotarget.10339. Oncotarget. 2017. PMID: 28199217 Free PMC article.

8

Methylated +322-327 CpG site decreases hOGG1 mRNA expression in non-small cell lung cancer.

Zeng Y, Zhu J, Qin H, Shen D, Lei Z, Li W, Ding Z, Huang JA, Liu Z. Zeng Y, et al. Among authors: shen d. Oncol Rep. 2017 Jul;38(1):529-537. doi: 10.3892/or.2017.5690. Epub 2017 Jun 1. Oncol Rep. 2017. PMID: 28586012

9

Variant SNPs at the microRNA complementary site in the B7‑H1 3'‑untranslated region increase the risk of non‑small cell lung cancer.

Du W, Zhu J, Chen Y, Zeng Y, Shen D, Zhang N, Ning W, Liu Z, Huang JA. Du W, et al. Among authors: shen d. Mol Med Rep. 2017 Sep;16(3):2682-2690. doi: 10.3892/mmr.2017.6902. Epub 2017 Jun 30. Mol Med Rep. 2017. PMID: 28677815 Free PMC article.

10

A Pilot Study of a Novel through-the-Scope Self-Expandable Metallic Airway Stents Delivery System in Malignant Central Airway Obstruction.

Jiang JH, Zeng DX, Wang CG, Chen YB, Shen D, Mao JY, Turner JF Jr, Huang JA. Jiang JH, et al. Among authors: shen d. Can Respir J. 2019 May 12;2019:7828526. doi: 10.1155/2019/7828526. eCollection 2019. Can Respir J. 2019. PMID: 31214271 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,363 results

Search Page

Filters